{"id":"958016f1-fcac-4eaa-bf58-1eb579695bae","kind":"news","code":"958016f1-fcac-4eaa-bf58-1eb579695bae","name":"iRegene completes equity financing","nameBasis":"translated-title","summary":"On 2026-03-19, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Xiangfeng Investment.","description":"","country":null,"category":null,"originalName":"睿健医药完成股权投资融资","eventDate":"2026-03-19T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-18T17:28:16.907Z","englishUpdatedAt":"2026-10-20T18:21:37.644Z","reviewedAt":"2026-10-20T18:21:37.644Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"ca504adcd6cffd9ffd8e1319ad20b0361c4d506a3471ccdf60a559680063802e","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"originalText":"2026年3月19日，据烯牛数据报道，睿健医药完成股权投资融资，金额未披露。投资方为祥峰投资。","sources":[],"related":[{"id":"b10e76c0-1d83-4ad6-9a53-a19944cf383b","kind":"institutions","code":"UB-I203","name":"Xiangfeng Investment","nameBasis":"transliterated","summary":"Vertex Ventures' venture capital entity in China, focused on early-stage technology and consumer enterprise investments and operating independently of Vertex Ventures US.","description":"Vertex Ventures' venture capital entity in China, focused on early-stage technology and consumer enterprise investments and operating independently of Vertex Ventures US.","country":"Singapore","category":null,"originalName":"祥峰投资","eventDate":null,"website":"https://www.vertexventures.cn/","sourceUpdatedAt":"2026-10-18T22:00:14.308Z","englishUpdatedAt":"2026-10-20T18:27:03.237Z","reviewedAt":"2026-10-20T18:27:03.237Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"6a785cb422820ddbc75bd4f041893c4004e7036698af725c465c9c472850ef1a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/xiangfeng-investment"},{"id":"c6f40f74-5248-4720-8404-fd1e03022e90","kind":"companies","code":"UB-C5987","name":"iRegene","nameBasis":"source-english","summary":"AI and chemically induced cell drug research and development.","description":"","country":"China","category":null,"originalName":"睿健医药","eventDate":null,"website":"https://www.iregene.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.154Z","reviewedAt":"2026-10-20T18:26:36.154Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"4f1558709e5410f70940856de858bdad558b4dea9749771117809729b847f483","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C5987"}],"path":"/news/958016f1-fcac-4eaa-bf58-1eb579695bae","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"iRegene","path":"/companies/UB-C5987"}},"canonical":"https://uniquebase.ai/news/958016f1-fcac-4eaa-bf58-1eb579695bae"}